University Of Athens
Clinical trials sponsored by University Of Athens, explained in plain language.
-
Diabetes drug combo may shield hearts: new trial launches
Disease control Recruiting nowThis study looks at whether combining two common diabetes medications (GLP-1 agonists and SGLT2 inhibitors) can improve heart function and blood vessel health in people with type 2 diabetes who are at high risk for heart problems. About 240 participants will be split into four gr…
Sponsor: University of Athens • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Could a diabetes pill mend hearts after a heart attack?
Disease control Recruiting nowThis study looks at whether empagliflozin, a diabetes drug, can help blood vessels and heart function recover after a heart attack. About 80 adults who had a severe heart attack will either receive the drug or standard care. Researchers will measure artery stiffness, heart strain…
Sponsor: University of Athens • Aim: Disease control
Last updated May 05, 2026 11:53 UTC
-
New study probes link between Little-Known blood fat and heart risks
Knowledge-focused Recruiting nowThis study looks at how a specific blood fat called lipoprotein(a) might affect the stiffness of arteries, the health of blood vessel linings, and the heart's ability to pump. Researchers will follow 300 adults aged 18-75 for one year, measuring these factors and tracking any hea…
Sponsor: University of Athens • Aim: Knowledge-focused
Last updated May 17, 2026 04:15 UTC